1. Home
  2. CATX vs CHPT Comparison

CATX vs CHPT Comparison

Compare CATX & CHPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CATX
  • CHPT
  • Stock Information
  • Founded
  • CATX 1983
  • CHPT 2007
  • Country
  • CATX United States
  • CHPT United States
  • Employees
  • CATX N/A
  • CHPT N/A
  • Industry
  • CATX Medical/Dental Instruments
  • CHPT Industrial Specialties
  • Sector
  • CATX Health Care
  • CHPT Consumer Discretionary
  • Exchange
  • CATX Nasdaq
  • CHPT Nasdaq
  • Market Cap
  • CATX 239.0M
  • CHPT 256.9M
  • IPO Year
  • CATX N/A
  • CHPT N/A
  • Fundamental
  • Price
  • CATX $2.73
  • CHPT $10.80
  • Analyst Decision
  • CATX Strong Buy
  • CHPT Hold
  • Analyst Count
  • CATX 10
  • CHPT 11
  • Target Price
  • CATX $12.30
  • CHPT $18.40
  • AVG Volume (30 Days)
  • CATX 1.7M
  • CHPT 404.4K
  • Earning Date
  • CATX 11-10-2025
  • CHPT 12-03-2025
  • Dividend Yield
  • CATX N/A
  • CHPT N/A
  • EPS Growth
  • CATX N/A
  • CHPT N/A
  • EPS
  • CATX N/A
  • CHPT N/A
  • Revenue
  • CATX $1,235,000.00
  • CHPT $397,731,000.00
  • Revenue This Year
  • CATX N/A
  • CHPT N/A
  • Revenue Next Year
  • CATX N/A
  • CHPT $12.63
  • P/E Ratio
  • CATX N/A
  • CHPT N/A
  • Revenue Growth
  • CATX N/A
  • CHPT N/A
  • 52 Week Low
  • CATX $1.60
  • CHPT $8.55
  • 52 Week High
  • CATX $12.90
  • CHPT $30.00
  • Technical
  • Relative Strength Index (RSI)
  • CATX 36.42
  • CHPT 47.22
  • Support Level
  • CATX $2.60
  • CHPT $10.40
  • Resistance Level
  • CATX $3.15
  • CHPT $11.13
  • Average True Range (ATR)
  • CATX 0.36
  • CHPT 0.53
  • MACD
  • CATX -0.15
  • CHPT -0.12
  • Stochastic Oscillator
  • CATX 5.12
  • CHPT 18.28

About CATX Perspective Therapeutics Inc.

Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.

About CHPT ChargePoint Holdings Inc.

ChargePoint Holdings Inc designs, develops, and markets networked electric vehicle charging system infrastructure and cloud-based services that enable consumers to locate, reserve, and authenticate EV charging. The company's hardware product lineup includes solutions across home, commercial, and fast-charging applications. ChargePoint derives the majority of its revenue from the United States.

Share on Social Networks: